The interplay of TARG1 and PARG protects against genomic instability

Cell Rep. 2023 Sep 26;42(9):113113. doi: 10.1016/j.celrep.2023.113113. Epub 2023 Sep 6.

Abstract

The timely removal of ADP-ribosylation is crucial for efficient DNA repair. However, much remains to be discovered about ADP-ribosylhydrolases. Here, we characterize the physiological role of TARG1, an ADP-ribosylhydrolase that removes aspartate/glutamate-linked ADP-ribosylation. We reveal its function in the DNA damage response and show that the loss of TARG1 sensitizes cells to inhibitors of topoisomerase II, ATR, and PARP. Furthermore, we find a PARP1-mediated synthetic lethal interaction between TARG1 and PARG, driven by the toxic accumulation of ADP-ribosylation, that induces replication stress and genomic instability. Finally, we show that histone PARylation factor 1 (HPF1) deficiency exacerbates the toxicity and genomic instability induced by excessive ADP-ribosylation, suggesting a close crosstalk between components of the serine- and aspartate/glutamate-linked ADP-ribosylation pathways. Altogether, our data identify TARG1 as a potential biomarker for the response of cancer cells to PARP and PARG inhibition and establish that the interplay of TARG1 and PARG protects cells against genomic instability.

Keywords: ADP-ribosylation; CP: Molecular biology; DNA damage; PARG inhibitor; PARP inhibitor; TARG1; cancer.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADP-Ribosylation
  • Aspartic Acid* / metabolism
  • Carrier Proteins / metabolism
  • Genomic Instability
  • Glutamates / metabolism
  • Humans
  • Nuclear Proteins / metabolism
  • Poly(ADP-ribose) Polymerase Inhibitors* / pharmacology

Substances

  • Poly(ADP-ribose) Polymerase Inhibitors
  • Aspartic Acid
  • Glutamates
  • HPF1 protein, human
  • Carrier Proteins
  • Nuclear Proteins